stockrow
Saturday 7 November 2026
Export AIRS’s income statement to Excel — free account
AirSculpt Technologies, Inc.
AIRS Healthcare Medical Care Facilities
AirSculpt Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $151.8 million, down 15.8% from fiscal 2024.
- Revenue
- −8.71%
- EPS
- +33.3%
- Free cash flow
- −813.8%
- Total debt
- −90.4%
Quarter to September 2026, against a year earlier
0.55
0.89
−61.81%
Follow AIRS
Alert me
| Sep '26 From the 10-Q filed 6 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
— | 6 | 5 | 3 |
+8 more TTM periods Free account |
| 0.00% | (11.98%) | (12.63%) | (14.07%) | ||
| 0.00% | (5.99%) | (5.68%) | (5.83%) | ||
ROIC |
0.00% | (6.07%) | (5.73%) | (5.34%) | |
Return on Tangible Assets |
0.00% | (68.87%) | (62.81%) | (75.92%) | |
Average Days of Receivables |
4.29 | 5.72 | 4.75 | 3.60 | |
Free Cash Flow per Share |
(0.03) | 0.01 | 0.10 | 0.01 | |
Free Cash Flow |
(2.54) | 0.76 | 6.95 | 0.69 | |
Capital Expenditures |
(0.56) | (0.52) | (0.55) | (2.40) | |
| Other line items | |||||
Cash ROIC |
(2.00%) | 0.45% | 4.29% | 0.45% | |
Accounts Receivable Turnover |
56.89 | 72.34 | 56.89 | 66.66 | |
Accounts Payable Turnover |
0.00 | 11.46 | 10.58 | 10.61 | |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 43.65 | 44.39 | 31.76 | |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | (0.34) | (0.35) | (0.34) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
57.21% | 55.56% | 54.66% | 54.13% | |
Share Based Compensation of Revenue |
0.80% | 0.80% | 1.09% | 1.54% | |
Interest Coverage |
0.00 | (2.45) | (2.08) | (1.90) | |
Operating CF/Net income |
0.00 | (0.11) | (0.67) | (0.27) | |
Depreciation/Fixed assets |
0.52 | 0.50 | 0.48 | 0.46 | |
Capex/Depreciation |
(0.05) | (0.04) | (0.04) | (0.19) | |
Revenue per Share |
2.04 | 2.13 | 2.19 | 2.51 | |
Operating CF per Share |
(0.03) | 0.02 | 0.11 | 0.05 | |
Capex per Share |
(0.01) | (0.01) | (0.01) | (0.04) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.02 |
Columns are period end dates · fundamentals updated 6 Nov 2026